Stents can be placed within the mammalian vasculature using endovascular techniques for the treatment of diseased vessels. Applications of stents include treatment of stenotic and atherosclerotic lesions in the coronary, peripheral, and cerebral vasculature. Another common application of stents is the treatment of cerebral aneurysms. Stents are designed to oppose the subject's inner vascular walls and provide an unobstructed conduit for blood flow within the stent lumen.
Stents are generally designed as straight homogenous tubes using biocompatible materials designed to treat the vessel pathology. Placing stents into vessel bifurcations requires deployment of multiple stents given the materials currently available. When more than one device is placed with overlap, the risk of complication exponentially increases—vessel wall apposition is decreased and stent material of an overlapped stent extends into the vessel lumen more than stent material of a single, non-overlapping stent would extend into the vessel.
There are several stent designs to overcome the problems associated with a bifurcation, but no current design is completely satisfactory for all applications. Highly flexible stents have been designed to fit the curvature of a bifurcated vessel but are not capable of extending through multiple branched vessels. Flexible stents with expanding elements may extend through bifurcated vessels slightly more, yet still incompletely. Other bifurcation reconstruction devices offer a solution for bifurcations but do not allow customization.
In illustrative embodiments, a self-expanding stent is disclosed, the self-expanding stent having a collapsed configuration and an expanded configuration. The self-expanding stent includes three stent subunits, which each include one or more longitudinally-oriented diamonds and one or more axially-oriented diamonds, as more fully described below. In an illustrative embodiment, the three subunits are oriented in the same plane and their terminal longitudinal diamonds are coupled together by a connector at a pivot joint. The terminal axial diamonds of the first subunit are also connected to axial subunits of the second and third stent subunits. The longitudinally-oriented diamonds are configured to substantially hold their shape in both the expanded configuration of the stent and the collapsed configuration of the stent. The axially-oriented diamonds are configured to expand from the collapsed configuration to the expanded configuration. The design allows the angle between the first stent subunit and the second and third stent subunits to enlarge with stent crimping and lessen with stent expansion. Thus, the stent can be inserted into a target location through a tubular catheter, and after the stent is no longer constrained by the catheter, it will expand to an angled configuration.
In another illustrative embodiment, the three subunits and connectors are replaced by a single component incorporating the shape and function described above. This can be accomplished by three-dimensional printing of a shape-memory material. This method allows for full customization of the stent, with respect to 1) stent angulation with expansion, 2) regional porosity, 3) regional stent radial force, 4) length of each subunit, 5) regional drug-elution, and 6) additional unforeseen customization requirements.
An illustrated stent 10 in which the principles of the present disclosure may be implemented includes a first stent component 14, a second stent component 12 that is bifurcated or branched, and one or more junction points 16 configured to join the first second component 14 to the second stent component 12 at a junctional region 38. The first stent component 14 and second stent component 12 are configured to include one or more longitudinally-oriented diamonds 30 and one or more axially-oriented diamonds 32 that, in part, form the structure of the stent 10. As illustrated in
To form the stent 10, the first stent component 14 is coupled to the second stent component 12 at apices 42 of the longitudinally-oriented diamonds 30. When the stent 10 is in a collapsed state, the stent 10 may be inserted into a patient's blood vessel, for instance by a catheter (not shown), during angioplasty or other types of medical procedures and positioned to expand in the vessel at a point where the vessel branches or bifurcates into two or more vessels. The use of such catheter or insertion techniques may be as described in pending application number WO 2013/009976, the contents of which are incorporated herein by reference.
The first stent component 14 and the second stent component 12 of the stent 10 are self-expanding elements. The first stent component 14 is configured to be placed in the proximal lumen of a vessel prior to a bifurcation; the second stent component 12 is configured to be placed in the lumens of both distal vessels of a bifurcation (after the bifurcation occurs). The second stent component 12 can be produced as two joined subunits 24 or as a single piece. The two stent components 14, 12 will be connected at the junction point 16 at apices 42, 44 of the longitudinally-oriented and axially-oriented diamonds 30, 32, respectively, so that the junctional region 38 is aligned with a bifurcating point of the blood vessels (not shown) after the stent 10 is deployed in an expanded state. In an illustrative embodiment, the first stent component 14 and the second stent component 12 are laser-cut from Nitinol tubing, but other materials and methods are envisioned.
In illustrative embodiments, a longitudinally-oriented diamond 30a from a first subunit 24 is coupled to a longitudinally-oriented diamond 30b from a second subunit 24 at the apex or apices 42a and 42b of the longitudinally-oriented diamonds 30a and 30b, respectively. Therefore, pivot joint 34 is formed by connecting the apices 42a and 42b and may be cut from the same nitinol tube as both arms 20, 22 or the longitudinally-oriented diamonds 30a and 30b. In alternative embodiments, the longitudinally-oriented diamonds 30a and 30b or their apices 42a and 42b may be altered to allow a separate nitinol, other metal (including platinum or other radiopaque metal), or other biocompatible joining mechanism to be used to form the pivot joint 34.
The bottom of the second stent component 12 may be open so that the lumen of the second stent component 12 can communicate or be joined with another component or subunit 24, including but not limited to the first stent component 14. This connection may be configured to be located at or near the pivot joint 34. The top of the second stent component 12 may include a junctional region 38 that allows additional stent coverage with minimal loss of flexibility the pivot joint 34 of the stent 10. In one embodiment, the junctional region 38 may include first and second scaffolding 40a and 40b, as illustrated in
In illustrative embodiments, the stent 10 may be inserted into the vessel through the use of a catheter (not shown), as more fully described in WO 2013/009976. For example, the catheter may constrain the stent 10 as it is inserted into the vessel, and then the catheter may be removed or modified such that it no longer constrains the stent 10. When the stent 10 is no longer constrained, it naturally expands to an expanded configuration, as shown in
Another junction point 16c connects the arm 20 of the second stent component 12 with the first component 14 by connecting an apex 44a of an axially-oriented diamond 32a of the arm 20 and an apex 44c of an axially-oriented diamond 32c of the first stent component 14. The last junction point 16d connects the arm 22 of the second stent component 12 with the first component 14 by connecting an apex 44b of an axially-oriented diamond 32b of the arm 22 and an apex 44c of an axially-oriented diamond 32c of the first stent component 14. Similar to the joining of stent components 20,22 at junction 34 in
Another junction point 16b connects the arm 20 of the second stent component 12 with the first component 14 by connecting an apex 44a of an axially-oriented diamond 32a of the arm 20 and an apex 44c of an axially-oriented diamond 32c of the first stent component 14. The last junction point 16d connects the arm 22 of the second stent component 12 with the first component 14 by connecting the apex 44b of an axially-oriented diamond 32b of the arm 22 and an apex 44c of an axially-oriented diamond 32b of the first stent component 14. Similar to the joining of the stent components 20, 22 at junction 34 in
Because a stent 10 once deployed/expanded will assume a precise and expected orientation within a blood vessel, the stent 10 can be modified to meet the needs of a particular patient's anatomy and pathology. The example stent 10 as described and shown in the FIGS. is merely a basic scaffold structure upon which an infinite number of additional stent features may be added or modified. Such features include, but are not limited to: variable porosity along the site of pathology or for protection of normal anatomy; matching of a bifurcation angle by changing the angle ratios of the longitudinally-oriented diamonds 30 or axially-oriented diamonds 32 of the stent 10; variation of size of the arms 20, 22 of the second stent component 12; and variation of diameter of the stent subunits 24.
In illustrative embodiments, in the open or expanded state, the stent 10 may be branched so that the distal arms 20 and 22 of the second stent component 12 form an angle with the first stent component 14, typically between 90 and 180 degrees. Thus, an angle between the two distal arms 20 and 22 may be between 0 to 180 degrees. This angle may be maintained by the bend of the second stent component 12 at the junctional region 38.
In illustrative embodiments, in the closed or collapsed state, the stent 10 may be configured to pass through a single catheter lumen (not shown) before reaching the end of the deployment catheter (not shown). In this collapsed state, the angle between the first stent component 14 and the arms 20 and 22 of the second stent component 12 must approximate 180 degrees. Thus, the arms 20 and 22 of the second stent component 12 must be bent so that they are parallel to each other during delivery through the catheter. The branched wire 50 may assist with delivery or deployment of the stent 10 in the catheter and/or blood vessel. Thus, unique features of the stent design allow the stent 10 to be delivered as a single unit, where the collapsed state is ideal for delivery, and the expanded state is ideal for final stent position, particularly in a bifurcated vessel.
Examples of use are provided herein for illustrative purposes, and are not intended to limit the scope of the disclosure. In one embodiment, the stent 10 may be used for the treatment of an intracranial aneurysm. The second stent component 12 may be deployed with or without the first stent component 14 to cover a neck of the intracranial aneurysm in order to aid in curative embolization. In another embodiment, the stent 10 may be used to treat stenosis of the vessels at a bifurcation. Bifurcations include, but are not limited to, those of the coronary arteries, carotid arteries, intracranial arteries, aortic bifurcation, and peripheral vessels.
This application claims the benefit of priority under 35 U.S.C. §119(e) to U.S. Provisional Application No. 61/778,040, filed Mar. 12, 2013. The disclosures set forth in the referenced application is incorporated herein by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US14/16917 | 2/18/2014 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
61778040 | Mar 2013 | US |